487 related articles for article (PubMed ID: 25016698)
1. Frequency of beta-thalassemia or beta-hemoglobinopathy carriers simultaneously affected with alpha-thalassemia in Iran.
Alizadeh S; Bavarsad MS; Dorgalaleh A; Khatib ZK; Dargahi H; Nassiri N; Hamid F; Rahim F; Jaseb K; Saki N
Clin Lab; 2014; 60(6):941-9. PubMed ID: 25016698
[TBL] [Abstract][Full Text] [Related]
2. Co-inheritance of alpha-and beta-thalassemia in Khuzestan Province, Iran.
Rahim F; Kaikhaei B; Zandian K; Hoseini A
Hematology; 2008 Feb; 13(1):59-64. PubMed ID: 18534068
[TBL] [Abstract][Full Text] [Related]
3. Study of Clinical, Hematological and Molecular Characteristics of Patients of Thalassemia and Hemoglobinopathies in Tertiary Care Hospital.
Kumar A; Gupta DK; Saluja S
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443538
[TBL] [Abstract][Full Text] [Related]
4. [A study on gene mutation spectrums of α- and β-thalassemias in populations of Yunnan Province and the prenatal gene diagnosis].
Zhu BS; He J; Zhang J; Zeng XH; Su J; Xu XH; Li SY; Chen H; Zhang YH
Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):85-9. PubMed ID: 22455737
[TBL] [Abstract][Full Text] [Related]
5. Ten Years of Routine α- and β-Globin Gene Sequencing in UK Hemoglobinopathy Referrals Reveals 60 Novel Mutations.
Henderson SJ; Timbs AT; McCarthy J; Gallienne AE; Proven M; Rugless MJ; Lopez H; Eglinton J; Dziedzic D; Beardsall M; Khalil MS; Old JM
Hemoglobin; 2016; 40(2):75-84. PubMed ID: 26635043
[TBL] [Abstract][Full Text] [Related]
6. Molecular prevalence of thalassemia and hemoglobinopathies among the Lao Loum Group in the Lao People's Democratic Republic.
Phanmany S; Chanprasert S; Munkongdee T; Svasti S; Leecharoenkiat K
Int J Lab Hematol; 2019 Oct; 41(5):650-656. PubMed ID: 31271507
[TBL] [Abstract][Full Text] [Related]
7. Molecular and geographical heterogeneity of hemoglobinopathy mutations in Azerbaijanian populations.
Aliyeva G; Asadov C; Mammadova T; Gafarova S; Guliyeva Y; Abdulalimov E
Ann Hum Genet; 2020 May; 84(3):249-258. PubMed ID: 31755088
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of thalassemia and hemoglobinopathy in Southeastern China.
Huang H; Xu L; Chen M; Lin N; Xue H; Chen L; Wang Y; He D; Zhang M; Lin Y
Sci Rep; 2019 Mar; 9(1):3493. PubMed ID: 30837609
[TBL] [Abstract][Full Text] [Related]
9. Correlation of beta-thalassemia mutations with alpha-thalassemia: an experience of the southwestern region of Iran.
Rahim F
Hematology; 2010 Dec; 15(6):430-3. PubMed ID: 21114907
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and genetic analysis of α-thalassemia and β-thalassemia in Chongqing area of China.
Yao XY; Yu J; Chen SP; Xiao JW; Zheng QC; Liu HY; Zhang L; Xian Y; Zou L
Gene; 2013 Dec; 532(1):120-4. PubMed ID: 24055728
[TBL] [Abstract][Full Text] [Related]
11. Effects of α-thalassaemia mutations on the haematological parameters of β-thalassaemia carriers.
Saleh-Gohari N; Khademi Bami M; Nikbakht R; Karimi-Maleh H
J Clin Pathol; 2015 Jul; 68(7):562-6. PubMed ID: 25935548
[TBL] [Abstract][Full Text] [Related]
12. Distribution of thalassemias and associated hemoglobinopathies identified by prenatal diagnosis in Taiwan.
Peng CT; Liu SC; Peng YC; Lin TH; Wang SJ; Le CY; Shih MC; Tien N; Lu JJ; Lin CY
Blood Cells Mol Dis; 2013 Oct; 51(3):138-41. PubMed ID: 23689197
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of Hemoglobinopathies in the Huzhou Region, Zhejiang Province, Southeast China.
Ding ZY; Shen GS; Zhang S; He PY
Hemoglobin; 2016 Sep; 40(5):304-309. PubMed ID: 27615034
[TBL] [Abstract][Full Text] [Related]
14. Genotype and phenotype characterizations in a large cohort of β-thalassemia heterozygote with different forms of α-thalassemia in northeast Thailand.
Yamsri S; Sanchaisuriya K; Fucharoen G; Sae-Ung N; Fucharoen S
Blood Cells Mol Dis; 2011 Aug; 47(2):120-4. PubMed ID: 21664157
[TBL] [Abstract][Full Text] [Related]
15. Carrier screening for thalassemia and hemoglobinopathies in Canada.
Langlois S; Ford JC; Chitayat D; ;
J Obstet Gynaecol Can; 2008 Oct; 30(10):950-959. PubMed ID: 19038079
[TBL] [Abstract][Full Text] [Related]
16. [Molecular epidemiological analysis of α- and β-thalassemia in Fujian province].
Xu LP; Huang HL; Wang Y; Zheng L; Wang LS; Xu JB; Huang XX; Lin Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Aug; 30(4):403-6. PubMed ID: 23926004
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and genotypes of alpha- and beta-thalassemia carriers in Hong Kong -- implications for population screening.
Lau YL; Chan LC; Chan YY; Ha SY; Yeung CY; Waye JS; Chui DH
N Engl J Med; 1997 May; 336(18):1298-301. PubMed ID: 9113933
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of hematological characteristics on the 79 co-inheritance of α-thalassemia and β-thalassemia carriers in Guangxi].
Xiong F; Lou JW; Wei XF; Sun MN; Huang JW; Shang X; Zhang XH; Xu XM
Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):856-60. PubMed ID: 23384911
[TBL] [Abstract][Full Text] [Related]
19. Can Couples With MCV≥80, MCH<26, HbA2<3.2, HbF<3 be Classified as Low-risk β-Thalassemia Group?
Mirzakhani M; Tarrahi MJ; Baghersad A; Maracy MR
J Pediatr Hematol Oncol; 2019 May; 41(4):303-306. PubMed ID: 30676434
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiological and hematological profile of thalassemia in the Dongguan Region of Guangdong Province, Southern China.
Peng Q; Zhang Z; Li S; Cheng C; Li W; Rao C; Zhong B; Lu X
J Clin Lab Anal; 2021 Feb; 35(2):e23596. PubMed ID: 32986258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
